Lean Life Science and Cancer Research UK Launch the Oncology Development Programme (ODP2) to Accelerate Development of High Impact Novel Cancer Innovations ApconiX is very excited to be part of Oncology Development Programme2 (ODP2) the latest Development Programme launched on the 21st of November at Alderley Park focused on [...]
In Silico/Mechanistic And Discovery Toxicology Speciality Sections’ Joint Workshop: Hands-On Modelling of Safety Data For Non-Experts Nicholas Coltman joined Layla Hosseini-Gerami, Andreas Bender, Srijit Seal (University of Cambridge) and Carolin Schramm (UCB) to organise this free online British Toxicology Society event on the 29th of November 2022 at 2pm [...]
ApconiX Is Recruiting Experienced Target Safety Biologists (Principal Scientist) ApconiX is a team of world-renowned nonclinical safety experts with over 500 years of drug discovery and development expertise. We were formed in 2015 by three scientists with the drive and ambition to create a world-renowned company. We are now [...]
GRC - Cellular and Molecular Mechanisms of Toxicity Dr Rhiannon Hardwick (BMS), Conference Chair, will be joined by Professor Heather Wallace, University of Aberdeen as Vice Chair of the Gordon Research Conference (GRC) Cellular and Molecular Mechanisms of Toxicity - Modernized Approaches to Mechanistic Toxicology Investigations at the Proctor [...]
ApconiX Welcomes Dr Craig Thomas ApconiX is delighted to welcome Dr Craig Thomas who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Craig has thirty-four years of drug discovery and management experience in the pharmaceutical industry. Working in both drug discovery, regulatory [...]
ApconiX Welcomes Dr Amy Shepherd ApconiX is delighted to welcome Dr Amy Shepherd who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Amy is an experienced immunologist having worked for over 10 years in nonclinical and clinical safety program design with both [...]
ApconiX Welcomes Scott Hackford ApconiX is delighted to welcome Scott Hackford who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Scott has over 12 years’ experience in a contract research organisation as a study director and lead toxicologist designing, conducting, and reporting [...]
ApconiX Welcomes Bethan Kelly ApconiX is delighted to welcome Bethan Kelly who joins for a years’ placement having just completed her second year of a bachelor’s degree in biology. Bethan becomes part of the ion channel laboratory team and will be working with Dr Michael Morton. Studying Biology Bethan [...]
Celebrating the Link Between hERG and Whiskey Come and help us celebrate the link between hERG and whiskey at our Booth #A6. We’ll be at the ELRIG Drug Discovery 2022 on the 4th and 5th of October, 2022, in London, UK. hERG and Whiskey We’ll be giving away ApconiX [...]
ApconiX Welcomes Dr Kerry Illston ApconiX is delighted to welcome Dr Kerry Illston who joins the team of nonclinical safety experts and will be working with Dr Richard Knight. Kerry is an experienced Project Manager with over 25 years’ experience in molecular toxicology, new target identification/validation and nonclinical safety [...]
